PL1765863T3 - Związki oparte na peptydach - Google Patents
Związki oparte na peptydachInfo
- Publication number
- PL1765863T3 PL1765863T3 PL05752383T PL05752383T PL1765863T3 PL 1765863 T3 PL1765863 T3 PL 1765863T3 PL 05752383 T PL05752383 T PL 05752383T PL 05752383 T PL05752383 T PL 05752383T PL 1765863 T3 PL1765863 T3 PL 1765863T3
- Authority
- PL
- Poland
- Prior art keywords
- peptide
- based compounds
- angiogenesis
- optical imaging
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 238000012634 optical imaging Methods 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20042523 | 2004-06-16 | ||
| EP05752383A EP1765863B1 (en) | 2004-06-16 | 2005-06-15 | Peptide-based compounds |
| PCT/NO2005/000210 WO2005123768A1 (en) | 2004-06-16 | 2005-06-15 | Peptide-based compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1765863T3 true PL1765863T3 (pl) | 2012-05-31 |
Family
ID=34979156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05752383T PL1765863T3 (pl) | 2004-06-16 | 2005-06-15 | Związki oparte na peptydach |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7897142B2 (enExample) |
| EP (1) | EP1765863B1 (enExample) |
| JP (1) | JP5280683B2 (enExample) |
| CN (2) | CN101001870A (enExample) |
| AT (1) | ATE538135T1 (enExample) |
| BR (1) | BRPI0512209A (enExample) |
| ES (1) | ES2376557T3 (enExample) |
| PL (1) | PL1765863T3 (enExample) |
| RU (1) | RU2393167C2 (enExample) |
| WO (1) | WO2005123768A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
| DE602005025911D1 (de) * | 2004-11-22 | 2011-02-24 | Ge Healthcare As | Kontrastmittel für eine extrazelluläre matrix |
| ITMI20050328A1 (it) | 2005-03-03 | 2006-09-04 | Univ Degli Studi Milano | Composti peptidomimetrici e preparazione di derivati biologicamente attivi |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| CN102026671B (zh) * | 2008-03-14 | 2014-09-03 | Visen医药公司 | 整联蛋白靶向试剂及使用其的体内和体外成像方法 |
| US20100291706A1 (en) * | 2009-05-15 | 2010-11-18 | Millipore Corporation | Dye conjugates and methods of use |
| ES2398042T3 (es) * | 2009-10-21 | 2013-03-13 | Cyanagen Srl | Kit y procedimiento para el marcaje de biomoléculas |
| GB201010878D0 (en) | 2010-06-29 | 2010-08-11 | Ge Healthcare As | Dye compositiion and dye syntheses |
| CN103052690A (zh) | 2010-06-29 | 2013-04-17 | 通用电气医疗集团股份有限公司 | 染料组合物和染料合成 |
| CN104470546B (zh) * | 2012-07-20 | 2018-02-27 | 佳能株式会社 | 化合物和含有所述化合物的光声成像造影剂 |
| WO2014055253A1 (en) * | 2012-10-04 | 2014-04-10 | The General Hospital Corporation | Methods of synthesizing and using peg-like fluorochromes |
| WO2015059368A1 (fr) * | 2013-09-02 | 2015-04-30 | L'oreal | Procede de coloration des fibres keratiniques a partir de colorants cationiques styryles disulfures, et composition comprenant lesdits colorants |
| CN107022350A (zh) * | 2017-04-20 | 2017-08-08 | 深圳大学 | 一种荧光造影材料及其制备方法与应用 |
| CN107739528A (zh) * | 2017-09-30 | 2018-02-27 | 武汉工程大学 | 一种五肽改性菁染料化合物及其制备方法和应用 |
| IL287989B2 (en) | 2019-05-13 | 2025-07-01 | Bracco Imaging Spa | Modified cyanine dyes and their conjugates |
| JP7698318B2 (ja) * | 2020-03-30 | 2025-06-25 | 一丸ファルコス株式会社 | Ｖｉｐｒ２アンタゴニストペプチド |
| WO2022216450A1 (en) | 2021-04-07 | 2022-10-13 | Becton, Dickinson And Company | Water-soluble fluorescent polymeric dyes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4445065A1 (de) * | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
| DE19917713A1 (de) * | 1999-04-09 | 2000-10-19 | Diagnostikforschung Inst | Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik |
| CA2405469C (en) * | 2000-04-12 | 2012-03-20 | Amersham Health As | Integrin binding peptide derivatives |
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
| NO20033115D0 (no) * | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
-
2005
- 2005-06-15 RU RU2006144279/04A patent/RU2393167C2/ru not_active IP Right Cessation
- 2005-06-15 AT AT05752383T patent/ATE538135T1/de active
- 2005-06-15 JP JP2007516412A patent/JP5280683B2/ja not_active Expired - Fee Related
- 2005-06-15 BR BRPI0512209-0A patent/BRPI0512209A/pt not_active IP Right Cessation
- 2005-06-15 US US11/570,156 patent/US7897142B2/en not_active Expired - Fee Related
- 2005-06-15 EP EP05752383A patent/EP1765863B1/en not_active Expired - Lifetime
- 2005-06-15 CN CNA2005800273703A patent/CN101001870A/zh active Pending
- 2005-06-15 WO PCT/NO2005/000210 patent/WO2005123768A1/en not_active Ceased
- 2005-06-15 CN CNA2005800198740A patent/CN1968963A/zh active Pending
- 2005-06-15 PL PL05752383T patent/PL1765863T3/pl unknown
- 2005-06-15 ES ES05752383T patent/ES2376557T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1968963A (zh) | 2007-05-23 |
| RU2006144279A (ru) | 2008-07-27 |
| WO2005123768A1 (en) | 2005-12-29 |
| EP1765863B1 (en) | 2011-12-21 |
| US7897142B2 (en) | 2011-03-01 |
| ATE538135T1 (de) | 2012-01-15 |
| US20080095715A1 (en) | 2008-04-24 |
| BRPI0512209A (pt) | 2008-02-19 |
| ES2376557T3 (es) | 2012-03-14 |
| JP5280683B2 (ja) | 2013-09-04 |
| JP2008504237A (ja) | 2008-02-14 |
| RU2393167C2 (ru) | 2010-06-27 |
| CN101001870A (zh) | 2007-07-18 |
| EP1765863A1 (en) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1765863T3 (pl) | Związki oparte na peptydach | |
| NO20074036L (no) | Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer | |
| UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
| IL243840A0 (en) | Contrast agents for myocardial perfusion imaging | |
| EA201100231A1 (ru) | Диагностический анализ на основе антител | |
| EP1976558A4 (en) | USE OF AN IMMUNOGENIC PCV2 COMPOSITION FOR DEHUMIDIFYING SICKNESS SYMPTOMS IN PIGS | |
| ATE551073T1 (de) | Markierte hgf-bindende peptide für bildgebung | |
| EP2129294A4 (en) | COMBINATION OF TOMOGRAPHIC PICTURES IN SITU WITH A DIRECT VIEW IN STERILE ENVIRONMENTS | |
| UA105760C2 (uk) | Антитіло проти bst2 | |
| EP1732602A4 (en) | CYTOTOXICITY TRANSFER OF CELLS WITH NOTES ON SURFACE EXPRESSION OF MCSP | |
| MA29615B1 (fr) | Preparations et methodes pour le diagnostic et le traitement d'une tumeur | |
| EA200970923A1 (ru) | АНТИ-EpСАМ АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ | |
| WO2011045415A3 (en) | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases | |
| GT200600182A (es) | Anticuerpos dirigidos contra el peptido amiloide beta y metodo que utilizan los mismos | |
| WO2009129311A3 (en) | Somatostatin receptor 2 antagonists | |
| WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
| EP2170463A4 (en) | SEEDS AND MARKERS FOR USE IN IMAGING | |
| EA200870502A1 (ru) | Белки слияния на основе rage, их композиции и способы их применения | |
| NO20033115D0 (no) | Peptid-baserte forbindelser | |
| EP2340262A4 (en) | FORMULATIONS FOR IGFBP7 FOR DIAGNOSIS AND THERAPY OF CANCER | |
| EP2633063A4 (en) | CANCER IMAGING WITH THERAPY: THEROSIS | |
| EP4234634A3 (en) | Modified cyanine dyes and conjugates thereof | |
| EA200901142A1 (ru) | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники | |
| NO20071613L (no) | Forbindelser for myokardial perfusjons-billeddannelse | |
| MA34291B1 (fr) | Compositions et méthodes de diagnostic et de traitement d'une tumeur |